AU Patent

AU2023227779A1 — Compositions and methods for modulating nuclear factor of activated t-cells (nfat) activity of t cells

Assigned to Yale University · Expires 2024-09-12 · 2y expired

What this patent protects

The present invention relates to methods for modulating NFAT activity and/or restoring the suppressed Nuclear Factor of Activated T-cells (NFAT) activity in T cells of a subject in need thereof. In another aspect, the invention provides different herbal compositions for modulatin…

USPTO Abstract

The present invention relates to methods for modulating NFAT activity and/or restoring the suppressed Nuclear Factor of Activated T-cells (NFAT) activity in T cells of a subject in need thereof. In another aspect, the invention provides different herbal compositions for modulating NFAT activity in T cells of a subject in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023227779A1
Jurisdiction
AU
Classification
—
Expires
2024-09-12
Drug substance claim
No
Drug product claim
No
Assignee
Yale University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.